BST2 and cancer: Meta-analysis of TCGA (BRCA) human data that showed that BST-2 is most significantly associated with luminal B tumors, invasive ductal carcinoma, and metastatic tumors imply that BST-2 in cancer cells could be a prognostic factor for highly aggressive cancers.